🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, parallel-controlled study to compare th...
Status
Not Yet Recruiting
Location
Anhui Medical University Second Affiliated Hospital
Start Date
2026-09-05
Trial ID
NCT07776132
This randomized phase III trial studies docetaxel, carboplatin, trastuzumab...
Status
Completed
Location
Fairbanks Memorial Hospital
Start Date
2014-02-18
Trial ID
NCT02003209
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This phase II trial studies the immunologic response and side effects of us...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-04-20
Trial ID
NCT04329065
This is a randomised, double-blind, intravenous single-dose, four-arm paral...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2020-07-01
Trial ID
NCT04411550
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
This phase III trial evaluates the effect of adding locoregional therapy (s...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-03-09
Trial ID
NCT07578116
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of copanlisib...
Status
Terminated
Location
Los Angeles County-USC Medical Center
Start Date
2021-05-20
Trial ID
NCT04108858
Treatments Being Tested
This phase II MATCH treatment trial tests how well trastuzumab and pertuzum...
Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2017-03-23
Trial ID
NCT06136897
This randomized phase III trial studies how well paclitaxel, trastuzumab, a...
Status
Terminated
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-04-05
Trial ID
NCT03199885